Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Bronchioloalveolar carcinoma].

M Wislez1, V Gounant, J Cadranel

  • 1Service de pneumologie et de réanimation respiratoire, Hôpital Tenon, Paris. UPRES EA 3493, Université Paris VI, France.

Revue Des Maladies Respiratoires
|December 13, 2005
PubMed
Summary

Bronchioloalveolar carcinoma, a growing lung cancer subtype, presents unique diagnostic and treatment challenges. Advances in EGFR tyrosine kinase inhibitors offer new hope for managing this specific form of adenocarcinoma.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Four-Year Outcomes of First-Line Nivolumab Plus Ipilimumab for 6 Months Versus Continuation in Patients With Advanced NSCLC: Results of the Randomized IFCT-1701 "DICIPLE" Phase III Trial.

Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer·2026
Same author

AFSOS-SFRO Guidelines on Radiation-Induced Lung Injury.

Clinical lung cancer·2025
Same author

Savolitinib plus osimertinib in epidermal growth factor receptor (EGFR)-mutated advanced non-small cell lung cancer with MET overexpression and/or amplification following disease progression on osimertinib: primary results from the phase II SAVANNAH study.

Annals of oncology : official journal of the European Society for Medical Oncology·2025
Same author

[Diffuse idiopathic pulmonary neuroendocrine cell hyperplasia (DIPNECH)].

Revue des maladies respiratoires·2025
Same author

Real-world effectiveness and tolerability of sotorasib in patients with KRAS G12C-mutated metastatic non-small cell lung cancer: The IFCT-2102 Lung KG12Ci study.

European journal of cancer (Oxford, England : 1990)·2025
Same author

[The role of the pulmonologist in the therapeutic strategy for stage I bronchopulmonary cancers?]

Revue des maladies respiratoires·2024

Area of Science:

  • Pulmonology
  • Oncology
  • Pathology

Context:

  • Bronchioloalveolar carcinoma (BAC) is an increasing subtype of lung adenocarcinoma.
  • Its lepidic growth pattern along alveolar septa without invasion defines it histologically.
  • Diagnosis often requires high-resolution CT scans due to multifocal disease and ground glass opacities.

Purpose:

  • To review the diagnostic criteria and clinical presentation of bronchioloalveolar carcinoma.
  • To discuss current therapeutic strategies for solitary versus multifocal disease.
  • To highlight emerging treatment options for this specific lung cancer subtype.

Summary:

  • Bronchioloalveolar carcinoma (BAC) grows lepidically, requiring strict resection criteria for diagnosis.
  • High-resolution CT is crucial for evaluating multifocal disease and ground glass opacities.
  • While solitary nodules are resectable, diffuse forms have a poor prognosis with chemotherapy, but show promise with EGFR inhibitors.

Impact:

  • Improved understanding of BAC diagnosis and staging.
  • Current treatment paradigms for resectable and non-resectable BAC.
  • Potential for novel therapeutic strategies targeting EGFR in advanced BAC.

Related Experiment Videos